Related Experiment Video
Updated: Mar 22, 2026

08:58
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
Published on: July 5, 2018
13.3K
Characterization of CD200 Ectodomain Shedding
Karrie K Wong1, Fang Zhu1,2, Ismat Khatri2
1Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Plos One
|April 26, 2016
Summary
Soluble CD200 (sCD200), elevated in Chronic Lymphocytic Leukemia (CLL), is shed from cell surfaces. This shed sCD200 retains its functional extracellular domain, crucial for CD200 receptor interactions.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Soluble CD200 (sCD200) is present in human plasma and elevated in Chronic Lymphocytic Leukemia (CLL).
- CLL cells constitutively release CD200, with partial attenuation by ADAM28 silencing.
Purpose of the Study:
- To investigate mechanisms of CD200 shedding beyond ADAM28.
- To biochemically analyze the shed form of CD200 (sCD200).
Main Methods:
- Biochemical analysis of sCD200 from purified CLL cells and transfected Hek293 cells.
- Antibody generation against extracellular or cytoplasmic CD200 regions.
- PMA stimulation to enhance shedding.
- Flow cytometry to monitor cell surface CD200 expression.
- Western blot analysis and functional studies with CD200R1 expressing cells.
Main Results:
- CD200 shedding is enhanced by PMA stimulation.
- Shed CD200 lacks the cytoplasmic domain but retains the functional extracellular domain.
- The shed extracellular domain is capable of binding to and phosphorylating CD200R.
Conclusions:
- Functionally active CD200 extracellular moiety is cleaved from cell surfaces via ectodomain shedding.
- This shedding mechanism contributes to elevated sCD200 levels in CLL.
Related Concept Videos
T Cell Activation and Clonal Selection
17.1K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.1K
Receptor Downregulation in MVBs
3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
3.0K
Pinching-off of Coated Vesicles
4.4K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
4.4K

